Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents
Circulation Research. 1992;70:856-863

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S. C.
Right arrow Articles by Allen, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, S. C.
Right arrow Articles by Allen, P. M.

Circulation Research, Vol 70, 856-863, Copyright © 1992 by American Heart Association

ARTICLES

Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis

SC Smith and PM Allen
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Mo 63110.

Tumor necrosis factor (TNF) and interferon gamma (IFN-gamma) are pluripotent cytokines and have multiple functions during the inflammatory response. Using a murine model of autoimmune myocarditis, we studied the role of TNF and IFN-gamma in myocardial inflammation. Neutralizing monoclonal antibodies against TNF-alpha/beta and IFN-gamma were administered to myosin-immunized A/J mice to assess the effect on the severity of myocardial inflammation. Anti-TNF treatment significantly reduced the severity of myocarditis compared with rat immunoglobulin G or saline controls (p less than 0.0007) when given before myosin immunization. Myosin-specific lymph node T-cell proliferation studies showed no difference in the proliferative response between the anti-TNF-treated mice and controls. Administration of anti-TNF to mice after myosin immunization had no effect on the severity of inflammation. This suggests that TNF is an important mediator early in the pathogenesis of myocardial inflammation in this model of myocarditis. Neutralization of IFN-gamma significantly increased the severity of myocarditis compared with rat immunoglobulin G and saline controls (p less than 0.0065), suggesting that IFN-gamma may function as an important regulatory cytokine early in the pathogenesis of myocardial inflammation. Understanding the functions of cytokines during the inflammatory response to myocardial injury may provide important information on possible methods to limit myocardial damage.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
A. Zampetaki, L. Zeng, Q. Xiao, A. Margariti, Y. Hu, and Q. Xu
Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-{alpha} is rescued by HDAC inhibitor trichostatin A
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1226 - C1238.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Reifenberg, H.-A. Lehr, M. Torzewski, G. Steige, E. Wiese, I. Kupper, C. Becker, S. Ott, P. Nusser, K.-I. Yamamura, et al.
Interferon-{gamma} Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
Am. J. Pathol., August 1, 2007; 171(2): 463 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
L. T. Cooper, R. Virmani, N. M. Chapman, A. Frustaci, R. J. Rodeheffer, M. W. Cunningham, and D. M. McNamara
National Institutes of Health-Sponsored Workshop on Inflammation and Immunity in Dilated Cardiomyopathy
Mayo Clin. Proc., February 1, 2006; 81(2): 199 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Afanasyeva, D. Georgakopoulos, D. F. Belardi, D. Bedja, D. Fairweather, Y. Wang, Z. Kaya, K. L. Gabrielson, E. R. Rodriguez, P. Caturegli, et al.
Impaired up-regulation of CD25 on CD4+ T cells in IFN-{gamma} knockout mice is associated with progression of myocarditis to heart failure
PNAS, January 4, 2005; 102(1): 180 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Guilherme, P. Cury, L. M.F. Demarchi, V. Coelho, L. Abel, A. P. Lopez, S. E. Oshiro, S. Aliotti, E. Cunha-Neto, P. M.A. Pomerantzeff, et al.
Rheumatic Heart Disease: Proinflammatory Cytokines Play a Role in the Progression and Maintenance of Valvular Lesions
Am. J. Pathol., November 1, 2004; 165(5): 1583 - 1591.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
U. M. Fischer, O. Klass, U. Stock, J. Easo, H. J. Geissler, J. H. Fischer, W. Bloch, and U. Mehlhorn
Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 984 - 990.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
M. Afanasyeva and N.R. Rose
Immune mediators in inflammatory heart disease: insights from a mouse model
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I31 - I36.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
M. Afanasyeva and N. R. Rose
Cardiomyopathy Is Linked to Complement Activation
Am. J. Pathol., August 1, 2002; 161(2): 351 - 357.
[Full Text] [PDF]

Home page
 HeartHome page
C G Densem, I V Hutchinson, N Yonan, and N H Brooks
Tumour necrosis factor {alpha} gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction?
Heart, February 1, 2002; 87(2): 153 - 155.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Afanasyeva, Y. Wang, Z. Kaya, E. A. Stafford, K. M. Dohmen, A. A. Sadighi Akha, and N. R. Rose
Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-{gamma}-Independent Pathway
Circulation, December 18, 2001; 104(25): 3145 - 3151.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Kishimoto, H. Takada, H. Kawamata, M. Umatake, and H. Ochiai
Immunoglobulin Treatment Prevents Congestive Heart Failure in Murine Encephalomyocarditis Viral Myocarditis Associated with Reduction of Inflammatory Cytokines
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 645 - 651.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. W. Cunningham
Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis
Am. J. Pathol., July 1, 2001; 159(1): 5 - 12.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Afanasyeva, Y. Wang, Z. Kaya, S. Park, M. J. Zilliox, B. H. Schofield, S. L. Hill, and N. R. Rose
Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype
Am. J. Pathol., July 1, 2001; 159(1): 193 - 203.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. M. Godsel, K. Wang, B. A. Schodin, J. S. Leon, S. D. Miller, and D. M. Engman
Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance
Circulation, March 27, 2001; 103(12): 1709 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Wada, K. Saito, T. Kanda, I. Kobayashi, H. Fujii, S. Fujigaki, N. Maekawa, H. Takatsu, H. Fujiwara, K. Sekikawa, et al.
Tumor Necrosis Factor-{{alpha}} (TNF-{{alpha}}) Plays a Protective Role in Acute Viral Myocarditis in Mice : A Study Using Mice Lacking TNF-{{alpha}}
Circulation, February 6, 2001; 103(5): 743 - 749.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. Kishimoto, N. Takamatsu, H. Kawamata, H. Shinohara, and H. Ochiai
Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1979 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Y. Wang, M. Afanasyeva, S. L. Hill, Z. Kaya, and N. R. Rose
Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1992 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Kubota, G. S. Bounoutas, M. Miyagishima, T. Kadokami, V. J. Sanders, C. Bruton, P. D. Robbins, C. F. McTiernan, and A. M. Feldman
Soluble Tumor Necrosis Factor Receptor Abrogates Myocardial Inflammation but Not Hypertrophy in Cytokine-Induced Cardiomyopathy
Circulation, May 30, 2000; 101(21): 2518 - 2525.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. S. Francis
TNF-{alpha} and Heart Failure : The Difference Between Proof of Principle and Hypothesis Testing
Circulation, June 29, 1999; 99(25): 3213 - 3214.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
G. Alloatti, C. Penna, A. De Martino, G. Montrucchio, and G. Camussi
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-{alpha} in the guinea-pig papillary muscle
Cardiovasc Res, March 1, 1999; 41(3): 611 - 619.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
A. Haunstetter and S. Izumo
Apoptosis : Basic Mechanisms and Implications for Cardiovascular Disease
Circ. Res., June 15, 1998; 82(11): 1111 - 1129.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
Y. Okura, K. Takeda, S. Honda, H. Hanawa, H. Watanabe, M. Kodama, T. Izumi, Y. Aizawa, S. Seki, and T. Abo
Recombinant Murine Interleukin-12 Facilitates Induction of Cardiac Myosin–Specific Type 1 Helper T Cells in Rats
Circ. Res., June 1, 1998; 82(10): 1035 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Ferrari
Tumor necrosis factor in CHF: a double facet cytokine
Cardiovasc Res, March 1, 1998; 37(3): 554 - 559.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
S. R. Kapadia, H. Oral, J. Lee, M. Nakano, G. E. Taffet, and D. L. Mann
Hemodynamic Regulation of Tumor Necrosis Factor-{alpha} Gene and Protein Expression in Adult Feline Myocardium
Circ. Res., August 19, 1997; 81(2): 187 - 195.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
H. Oral, G. W. Dorn II, and D. L. Mann
Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-alpha in the Adult Mammalian Cardiac Myocyte
J. Biol. Chem., February 21, 1997; 272(8): 4836 - 4842.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Libby and R. N. Mitchell
Cytokines Score a Knockout: Harnessing Gene Targeting to Gain Insight Into the Pathogenesis of Myocarditis
Circulation, February 4, 1997; 95(3): 551 - 552.
[Full Text]

Home page
 CirculationHome page
K. Bachmaier, C. Pummerer, I. Kozieradzki, K. Pfeffer, T. W. Mak, N. Neu, and J. M. Penninger
Low-Molecular-Weight Tumor Necrosis Factor Receptor p55 Controls Induction of Autoimmune Heart Disease
Circulation, February 4, 1997; 95(3): 655 - 661.
[Abstract] [Full Text]

Home page
 CirculationHome page
T. Shioi, A. Matsumori, and S. Sasayama
Persistent Expression of Cytokine in the Chronic Stage of Viral Myocarditis in Mice
Circulation, December 1, 1996; 94(11): 2930 - 2937.
[Abstract] [Full Text]

Home page
 Circ. Res.Home page
D. R. Murray and G. L. Freeman
Tumor Necrosis Factor-{alpha} Induces a Biphasic Effect on Myocardial Contractility in Conscious Dogs
Circ. Res., January 1, 1996; 78(1): 154 - 160.
[Abstract] [Full Text]

Home page
 CirculationHome page
G. Torre-Amione, S. Kapadia, J. Lee, R. D. Bies, R. Lebovitz, and D. L. Mann
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium
Circulation, September 15, 1995; 92(6): 1487 - 1493.
[Abstract] [Full Text]

Home page
 NEJMHome page
L. G. Lange and G. F. Schreiner
Immune Mechanisms of Cardiac Disease
N. Engl. J. Med., April 21, 1994; 330(16): 1129 - 1135.
[Full Text]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.